Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Survey of symptoms following COVID-19 vaccination in India
Rajeev Jayadevan, Ramesh Shenoy, Anithadevi TS
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Side effects and perceptions following Sinopharm COVID-19 vaccination
Balsam Qubais Saeed, Rula Al‐Shahrabi, Shaikha Salah Alhaj, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 219-226
Open Access | Times Cited: 243
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 556-556
Open Access | Times Cited: 197
Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE—An Observational Study
Subhashini Ganesan, Latifa Baynouna AlKetbi, Nawal Al Kaabi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 73
The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines
Tasnim Hasan, Justin Beardsley, Ben J. Marais, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 326-326
Open Access | Times Cited: 73
COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia
Yoseph Solomon, Tewodros Eshete, Bersabeh Mekasha, et al.
Journal of Multidisciplinary Healthcare (2021) Vol. Volume 14, pp. 2577-2585
Open Access | Times Cited: 66
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 289-315
Open Access | Times Cited: 64
Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan
Bilal Mahmood Beg, Tariq Hussain, Mehmood Ahmad, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266028-e0266028
Open Access | Times Cited: 60
Adverse effects following COVID-19 vaccination in Iran
Ebrahim Babaee, Ali Amirkafi, Arash Tehrani‐Banihashemi, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 48
Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study
Md Mohsin, Sultan Mahmud, Ashraf Uddin Mian, et al.
Vaccine X (2022) Vol. 12, pp. 100207-100207
Open Access | Times Cited: 26
Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: A cross sectional study from Pakistan
Ayaz Ali Samo, Raheela Bibi Sayed, Jeetandar Valecha, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Frequency of COVID‐19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: A cross‐sectional study
Farah Yasmin, Hala Najeeb, Hasan Fareed Siddiqui, et al.
Health Science Reports (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
Mohammad Ali Sahraian, Fereshteh Ghadiri, Amirreza Azimi, et al.
Vaccine (2021) Vol. 39, Iss. 43, pp. 6347-6350
Open Access | Times Cited: 31
Higher incidence of reported adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine among previously infected health care workers
Rajneesh Joshi, C.G. Muralidharan, Divyanee Gulati, et al.
Medical Journal Armed Forces India (2021) Vol. 77, pp. S505-S507
Open Access | Times Cited: 28
Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study
Muhammad Zahid
Vaccines (2021) Vol. 9, Iss. 11, pp. 1369-1369
Open Access | Times Cited: 27
Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia
Majid Darraj, Hesham M. Al‐Mekhlafi
Vaccines (2022) Vol. 10, Iss. 2, pp. 223-223
Open Access | Times Cited: 21
The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey
Mitiku Desalegn, Gelana Garoma, Habtamu Tamrat, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0265140-e0265140
Open Access | Times Cited: 19
Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
Heba M. Attash, Luma M. Al-Obaidy, Harith Al-Qazaz
Vaccines (2022) Vol. 10, Iss. 2, pp. 186-186
Open Access | Times Cited: 16
Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination
Balsam Qubais Saeed, Rula Al‐Shahrabi, Shaikha Salah Alhaj, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19
Acceptance and adverse effects following COVID-19 vaccination among the health care workers at a health care centre in the most backward district of India
Amita Sharma, Megha Jain, Monika Vigarniya
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 6, pp. 3224-3229
Open Access | Times Cited: 12
Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India
Md Anwarul Azim Majumder, Keerti Singh, WMS Johnson, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 161-174
Open Access | Times Cited: 7
Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system
Mostafa Enayatrad, Sepideh Mahdavi, Roqayeh Aliyari, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT
Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2022) Vol. 14, Iss. 1, pp. e2022026-e2022026
Open Access | Times Cited: 11
A Real World Evaluation of the safety and immunogenicity of the Covishield vaccine, ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) in Health Care Workers (HCW) in National Capital Region (NCR) of India: A preliminary report
Sushila Kataria, Pooja Sharma, Vikas Deswal, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 14
Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study
Prativa Subedi, Gopal Kumar Yadav, Binod Paudel, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260638-e0260638
Open Access | Times Cited: 14
Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians
Md Anwarul Azim Majumder, Afzalunnessa Binte Lutfor, Ahbab Mohammad Fazle Rabbi, et al.
FASEB BioAdvances (2022) Vol. 4, Iss. 6, pp. 379-390
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top